BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25541937)

  • 1. Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema: a meta-analysis of randomized controlled trials.
    Chen G; Li W; Tzekov R; Jiang F; Mao S; Tong Y
    PLoS One; 2014; 9(12):e115797. PubMed ID: 25541937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal ranibizumab (lucentis) for the treatment of diabetic macular edema: a systematic review and meta-analysis of randomized clinical control trials.
    Wang H; Sun X; Liu K; Xu X
    Curr Eye Res; 2012 Aug; 37(8):661-70. PubMed ID: 22631452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy/safety of ranibizumab monotherapy or with laser versus laser monotherapy in DME.
    Berger A; Sheidow T; Cruess AF; Arbour JD; Courseau AS; de Takacsy F
    Can J Ophthalmol; 2015 Jun; 50(3):209-16. PubMed ID: 26040221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.
    Ishibashi T; Li X; Koh A; Lai TY; Lee FL; Lee WK; Ma Z; Ohji M; Tan N; Cha SB; Shamsazar J; Yau CL;
    Ophthalmology; 2015 Jul; 122(7):1402-15. PubMed ID: 25983216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency and safety of laser photocoagulation with or without intravitreal ranibizumab for treatment of diabetic macular edema: a systematic review and Meta-analysis.
    Qian TW; Zhao MY; Li XX; Xu X
    Int J Ophthalmol; 2017; 10(7):1134-1143. PubMed ID: 28730118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal Ranibizumab in Diabetic Macular Edema: Long-Term Outcomes.
    Zucchiatti I; Bandello F
    Dev Ophthalmol; 2017; 60():63-70. PubMed ID: 28427066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
    Nguyen QD; Brown DM; Marcus DM; Boyer DS; Patel S; Feiner L; Gibson A; Sy J; Rundle AC; Hopkins JJ; Rubio RG; Ehrlich JS;
    Ophthalmology; 2012 Apr; 119(4):789-801. PubMed ID: 22330964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management paradigms for diabetic macular edema.
    Mitchell P; Wong TY;
    Am J Ophthalmol; 2014 Mar; 157(3):505-13.e1-8. PubMed ID: 24269850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.
    Mitchell P; Bressler N; Tolley K; Gallagher M; Petrillo J; Ferreira A; Wood R; Bandello F;
    JAMA Ophthalmol; 2013 Oct; 131(10):1339-47. PubMed ID: 23974915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema.
    Evoy KE; Abel SR
    Ann Pharmacother; 2013 Jun; 47(6):811-8. PubMed ID: 23656749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: A Bayesian network meta-analysis.
    Wu Y; Ai P; Ai Z; Xu G
    Biomed Pharmacother; 2018 Jan; 97():293-299. PubMed ID: 29091878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.
    Mi X; Gu X; Yu X
    Trials; 2022 Sep; 23(1):736. PubMed ID: 36056443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose).
    Do DV; Sepah YJ; Boyer D; Callanan D; Gallemore R; Bennett M; Marcus DM; Halperin L; Sadiq MA; Rajagopalan N; Campochiaro PA; Nguyen QD;
    Eye (Lond); 2015 Dec; 29(12):1538-44. PubMed ID: 26228291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials.
    Chen G; Li W; Tzekov R; Jiang F; Mao S; Tong Y
    Retina; 2015 Feb; 35(2):187-93. PubMed ID: 25105318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a Meta-analysis and systematic review.
    Liu WS; Li YJ
    Int J Ophthalmol; 2019; 12(9):1479-1486. PubMed ID: 31544046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
    Rajendram R; Fraser-Bell S; Kaines A; Michaelides M; Hamilton RD; Esposti SD; Peto T; Egan C; Bunce C; Leslie RD; Hykin PG
    Arch Ophthalmol; 2012 Aug; 130(8):972-9. PubMed ID: 22491395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
    Pearce I; Banerjee S; Burton BJ; Chakravarthy U; Downey L; Gale RP; Gibson J; Pagliarini S; Patel J; Sivaprasad S; Andrews C; Brittain C; Warburton J;
    Ophthalmology; 2015 Sep; 122(9):1811-9. PubMed ID: 26150052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
    Brown DM; Nguyen QD; Marcus DM; Boyer DS; Patel S; Feiner L; Schlottmann PG; Rundle AC; Zhang J; Rubio RG; Adamis AP; Ehrlich JS; Hopkins JJ;
    Ophthalmology; 2013 Oct; 120(10):2013-22. PubMed ID: 23706949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.